A Study to Assess the Relative Bioavailability of TMC207 Following Single-Dose Administrations of Two Pediatric Formulations in Healthy Adult Participants

NCT01803373 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy
Biological Availability

Interventions

DRUG: Treatment A (reference)
DRUG: Treatment B
DRUG: Treatment C

Sponsor

Janssen Infectious Diseases BVBA